Back

LINC02428, a liver-specific long noncoding RNA suppresses hepatocellular carcinoma progression

Zhang, Q.; Yan, L.; Chen, J.; Liu, L.

2022-09-21 cancer biology
10.1101/2022.09.21.508837 bioRxiv
Show abstract

There is growing evidence that lncRNAs play an important role in the progression of HCC, especially liver-specific expression of lncRNAs. LINC02428 is a liver-specific labeled lncRNA, but its role in HCC is unclear. We investigated the expression characteristics of LINC02428 in hepatocellular carcinoma tissues and analyzed its function in HCC. Using TCGA public data we found that the expression level of LINC02428 was significantly reduced in hepatocellular carcinoma tissues, compared to normal tissues. LINC02428 was also significantly reduced in hepatocellular carcinoma tissues in our cDNA microarray data from HCC patients. Survival analysis suggests that HCC patients with lower LINC02428 have a lower overall survival rate. In an in vitro analysis, overexpression of LINC02428 inhibited HCC cell proliferation, migration, and induced apoptosis. In conclusion, we report for the first time the expression profile of a liver-specific lncRNA, LINC02428, in HCC and confirmed its ability to inhibit the progression of HCC. LINC02428 may become a new target for the diagnosis and treatment of HCC.

Matching journals

The top 12 journals account for 50% of the predicted probability mass.

1
PLOS ONE
● 5266 papers in training set
Top 14%
13.1%
Similar papers in this journal
2
Frontiers in Genetics
○ 230 papers in training set
Top 0.4%
5.5%
Similar papers in this journal
3
PeerJ
◐ 308 papers in training set
Top 1%
4.9%
Similar papers in this journal
4
Frontiers in Oncology
○ 103 papers in training set
Top 0.8%
4.4%
Similar papers in this journal
5
Scientific Reports
○ 3612 papers in training set
Top 31%
3.3%
Similar papers in this journal
6
Biochemical and Biophysical Research Communications
○ 84 papers in training set
Top 0.4%
3.2%
7
BMC Cancer
○ 67 papers in training set
Top 0.7%
2.8%
8
Biochemistry and Biophysics Reports
○ 30 papers in training set
Top 0.1%
2.8%
9
Medicine
○ 31 papers in training set
Top 0.4%
2.8%
10
Heliyon
○ 152 papers in training set
Top 2%
2.7%
11
Molecular Biology Reports
○ 21 papers in training set
Top 0.2%
2.7%
12
RNA Biology
○ 78 papers in training set
Top 0.4%
2.7%
50% of probability mass above
13
eLife
● 5828 papers in training set
Top 42%
2.4%
14
Gene
○ 46 papers in training set
Top 0.5%
2.4%
15
Translational Oncology
○ 21 papers in training set
Top 0.2%
2.4%
16
International Journal of Molecular Sciences
○ 494 papers in training set
Top 6%
2.1%
17
Genomics, Proteomics & Bioinformatics
188 papers in training set
Top 0.9%
2.1%
18
Aging
○ 75 papers in training set
Top 0.7%
1.9%
19
Cancer Medicine
○ 26 papers in training set
Top 0.4%
1.9%
20
Cancers
○ 213 papers in training set
Top 3%
1.7%
21
Cell Death & Disease
147 papers in training set
Top 2%
1.1%
22
BioMed Research International
○ 28 papers in training set
Top 1%
1.1%
23
Computational Biology and Chemistry
○ 28 papers in training set
Top 0.7%
1.1%
24
Biomedical Signal Processing and Control
○ 22 papers in training set
Top 0.5%
1.0%
25
Journal of Translational Medicine
○ 57 papers in training set
Top 2%
1.0%
26
Bioscience Reports
● 27 papers in training set
Top 1%
0.9%
27
Biomedicines
○ 67 papers in training set
Top 3%
0.9%
28
Experimental Cell Research
○ 28 papers in training set
Top 0.6%
0.9%
29
Life Sciences
○ 27 papers in training set
Top 1%
0.9%
30
Genes
○ 144 papers in training set
Top 4%
0.9%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.